Sign in

Filings

Finds words inside filing documents. Searching Keros Therapeutics, Inc.'s filings · 69 documents indexed.

6 documents · 11 matches

  1. KROS Keros Therapeutics, Inc. 10-Q 2026-11-05

    Item 1 · Note 1. Nature of Business and Basis of Presentation

    going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of September
    2 matches in this document
  2. KROS Keros Therapeutics, Inc. 10-Q 2026-08-03

    Item 1 · Note 1. Nature of Business and Basis of Presentation

    going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of June
    2 matches in this document
  3. KROS Keros Therapeutics, Inc. 10-Q 2026-05-14

    Item 1 · Note 1. Nature of Business and Basis of Presentation

    going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of March
    2 matches in this document
  4. KROS Keros Therapeutics, Inc. 10-K 2026-03-04

    Item 16. Form 10-K Summary

    going concern for the next 12 months. Management believes that the Company’s $287.4 million cash and cash equivalents as of December
    1 match in this document
  5. KROS Keros Therapeutics, Inc. 10-Q 2025-11-05

    Item 1 · Note 1. Nature of Business and Basis of Presentation

    going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of September
    2 matches in this document
  6. KROS Keros Therapeutics, Inc. 10-Q 2025-08-06

    Item 1 · Note 1. Nature of Business and Basis of Presentation

    going concern for the next 12 months. Management believes that the Company’s existing cash and cash equivalents as of June
    2 matches in this document

Page 1 of 1 · 6 documents